SPITALUL DE URGENTA PETROSANI
A United Kingdom buyer, with 4 published contracts, worth £26.0m, most recently 7 months ago.
Top 2 suppliers won 100% of awarded value — £52.1m of £52.1m across 2 awards.
This framework agreement aims to establish subsequent contracts for the procurement of medicines for the treatment of individuals with HIV/AIDS and for post-exposure treatment (2024-2025). The specific medications include BICTEGRAVIR, EMTRICITABINE, and TENOFOVIR in dosages of 50 mg/200 mg/25 mg, as
